GlaxoSmithKline PLC Director/PDMR Shareholding (2791Q)
15 Febrero 2019 - 11:39AM
UK Regulatory
TIDMGSK
RNS Number : 2791Q
GlaxoSmithKline PLC
15 February 2019
GlaxoSmithKline plc (the 'Company')
Conditional Share Awards
On 13 February 2019, the Company granted awards to the Executive
Directors and Persons Discharging Managerial Responsibilities
(PDMRs) listed below. The awards have been granted in accordance
with the rules of the GlaxoSmithKline 2017 Deferred Annual Bonus
Plan (DABP) which was approved by shareholders on 4 May 2017.
Executive Directors are required to defer 50% of any bonus
earned into Ordinary Shares or ADSs for a period of three years.
Other participants are required to defer 25% of any bonus earned
into Ordinary Shares or ADSs for the same period.
With effect from 2018, DABP Matching Awards are no longer
granted.
The awards of deferred shares (Deferred Bonus Awards) have been
granted as conditional awards over ADSs for US participants and as
nil-cost options over Ordinary Shares for all other
participants.
The numbers of shares shown below are exclusive of dividend
reinvestment that will accrue during the deferral period.
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA')
==========================================================================================
a) Name Ms E Walmsley
==== ====================================== ==================================================
b) Position/status Chief Executive Officer
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Deferred Bonus Award of Ordinary Shares
transaction (under the GlaxoSmithKline 2017 Deferred
Annual Bonus Plan).
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP15.468 61,813
=================================================================== ======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2019-02-13
==== ====================================== ==================================================
f) Place of the transaction n/a
====================================== ==================================================
1. Details of PDMR/person closely associated with them ('PCA')
=========================================================================================
a) Name Dr H Barron
==== ====================================== =================================================
b) Position/status Chief Scientific Officer and President,
R&D
==== ====================================== =================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Deferred Bonus Award of Ordinary Shares
transaction (under the GlaxoSmithKline 2017 Deferred
Annual Bonus Plan).
==== ====================================== =================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ====================== ======================
$40.53 37,120
====================== ======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
======================================= =====================================================
e) Date of the transaction 2019-02-13
==== ====================================== =================================================
f) Place of the transaction n/a
====================================== =================================================
1. Details of PDMR/person closely associated with them ('PCA')
==========================================================================================
a) Name Mr R Connor
==== ====================================== ==================================================
b) Position/status President, Global Vaccines
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Deferred Bonus Award of Ordinary Shares
transaction (under the GlaxoSmithKline 2017 Deferred
Annual Bonus Plan).
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP15.468 16,223
=================================================================== ======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2019-02-13
==== ====================================== ==================================================
f) Place of the transaction n/a
====================================== ==================================================
1. Details of PDMR/person closely associated with them ('PCA')
==========================================================================================
a) Name Mr S Dingemans
==== ====================================== ==================================================
b) Position/status Chief Financial Officer
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Deferred Bonus Award of Ordinary Shares
transaction (under the GlaxoSmithKline 2017 Deferred
Annual Bonus Plan).
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP15.468 44,215
=================================================================== ======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2019-02-13
==== ====================================== ==================================================
f) Place of the transaction n/a
====================================== ==================================================
1. Details of PDMR/person closely associated with them ('PCA')
========================================================================================
a) Name Mr J Ford
==== ====================================== ================================================
b) Position/status SVP & General Counsel
==== ====================================== ================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W1053
==== ====================================== ================================================
b) Nature of the Deferred Bonus Award of ADSs (under the
transaction GlaxoSmithKline 2017 Deferred Annual Bonus
Plan).
==== ====================================== ================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ====================== =====================
$40.53 3,202
====================== =====================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
======================================= ====================================================
e) Date of the transaction 2019-02-13
==== ====================================== ================================================
f) Place of the transaction n/a
====================================== ================================================
1. Details of PDMR/person closely associated with them ('PCA')
==========================================================================================
a) Name Mr N Hirons
==== ====================================== ==================================================
b) Position/status SVP, Global Ethics and Compliance
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Deferred Bonus Award of Ordinary Shares
transaction (under the GlaxoSmithKline 2017 Deferred
Annual Bonus Plan).
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP15.468 6,801
=================================================================== ======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2019-02-13
==== ====================================== ==================================================
f) Place of the transaction n/a
====================================== ==================================================
1. Details of PDMR/person closely associated with them ('PCA')
==========================================================================================
a) Name Mr L Miels
==== ====================================== ==================================================
b) Position/status President, Global Pharmaceuticals
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Deferred Bonus Award of Ordinary Shares
transaction (under the GlaxoSmithKline 2017 Deferred
Annual Bonus Plan).
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP15.468 17,252
=================================================================== ======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2019-02-13
==== ====================================== ==================================================
f) Place of the transaction n/a
====================================== ==================================================
1. Details of PDMR/person closely associated with them ('PCA')
========================================================================================
a) Name Mr B McNamara
==== ====================================== ================================================
b) Position/status CEO, GSK Consumer Healthcare
==== ====================================== ================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W1053
==== ====================================== ================================================
b) Nature of the Deferred Bonus Award of ADSs (under the
transaction GlaxoSmithKline 2017 Deferred Annual Bonus
Plan).
==== ====================================== ================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ====================== =====================
$40.53 6,251
====================== =====================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
======================================= ====================================================
e) Date of the transaction 2019-02-13
==== ====================================== ================================================
f) Place of the transaction n/a
====================================== ================================================
1. Details of PDMR/person closely associated with them ('PCA')
==========================================================================================
a) Name Mr D Redfern
==== ====================================== ==================================================
b) Position/status Chief Strategy Officer
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Deferred Bonus Award of Ordinary Shares
transaction (under the GlaxoSmithKline 2017 Deferred
Annual Bonus Plan).
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP15.468 15,331
=================================================================== ======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2019-02-13
==== ====================================== ==================================================
f) Place of the transaction n/a
====================================== ==================================================
1. Details of PDMR/person closely associated with them ('PCA')
==========================================================================================
a) Name Mr R Simard
==== ====================================== ==================================================
b) Position/status President, Pharmaceuticals Supply Chain
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Deferred Bonus Award of Ordinary Shares
transaction (under the GlaxoSmithKline 2017 Deferred
Annual Bonus Plan).
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP15.468 5,540
=================================================================== ======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2019-02-13
==== ====================================== ==================================================
f) Place of the transaction n/a
====================================== ==================================================
1. Details of PDMR/person closely associated with them ('PCA')
==========================================================================================
a) Name Ms C Thomas
==== ====================================== ==================================================
b) Position/status SVP, Human Resources
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Deferred Bonus Award of Ordinary Shares
transaction (under the GlaxoSmithKline 2017 Deferred
Annual Bonus Plan).
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP15.468 13,098
=================================================================== ======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2019-02-13
==== ====================================== ==================================================
f) Place of the transaction n/a
====================================== ==================================================
1. Details of PDMR/person closely associated with them ('PCA')
==========================================================================================
a) Name Mr P Thomson
==== ====================================== ==================================================
b) Position/status President, Global Affairs
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the Deferred Bonus Award of Ordinary Shares
transaction (under the GlaxoSmithKline 2017 Deferred
Annual Bonus Plan).
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP15.468 8,972
=================================================================== ======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2019-02-13
==== ====================================== ==================================================
f) Place of the transaction n/a
====================================== ==================================================
1. Details of PDMR/person closely associated with them ('PCA')
========================================================================================
a) Name Ms K Terrell
==== ====================================== ================================================
b) Position/status Chief Digital & Technology Officer
==== ====================================== ================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W1053
==== ====================================== ================================================
b) Nature of the Deferred Bonus Award of ADSs (under the
transaction GlaxoSmithKline 2017 Deferred Annual Bonus
Plan).
==== ====================================== ================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ====================== =====================
$40.53 7,899
====================== =====================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
======================================= ====================================================
e) Date of the transaction 2019-02-13
==== ====================================== ================================================
f) Place of the transaction n/a
====================================== ================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHDELFFKLFLBBV
(END) Dow Jones Newswires
February 15, 2019 12:39 ET (17:39 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
